Crown ElectroKinetics Past Earnings Performance
Past criteria checks 0/6
Crown ElectroKinetics's earnings have been declining at an average annual rate of -18.5%, while the Chemicals industry saw earnings growing at 13.9% annually. Revenues have been declining at an average rate of 61.9% per year.
Key information
-18.5%
Earnings growth rate
17.9%
EPS growth rate
| Chemicals Industry Growth | 12.9% |
| Revenue growth rate | -61.9% |
| Return on equity | -619.7% |
| Net Margin | -19,385.6% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Crown ElectroKinetics reports Q2 results
Aug 15Crown Electrokinetics prices $1M share offering
Jul 20Crown ElectroKinetics EPS misses by $3.43
Jun 21Crown ElectroKinetics (CRKN ) Investor Presentation - Slideshow
Jun 14Loss-Making Crown ElectroKinetics Corp. (NASDAQ:CRKN) Expected To Breakeven In The Medium-Term
Mar 04
Revenue & Expenses BreakdownBeta
How Crown ElectroKinetics makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 0 | -30 | 15 | 2 |
| 30 Sep 23 | 0 | -22 | 13 | 2 |
| 30 Jun 23 | 0 | -22 | 13 | 3 |
| 31 Mar 23 | 0 | -12 | 11 | 4 |
| 31 Dec 22 | 0 | -14 | 10 | 4 |
| 30 Sep 22 | 0 | -18 | 13 | 5 |
| 30 Jun 22 | 0 | -20 | 16 | 5 |
| 31 Mar 22 | 0 | -21 | 18 | 4 |
| 31 Dec 21 | 0 | -37 | 19 | 3 |
| 30 Sep 21 | 0 | -36 | 16 | 3 |
| 30 Jun 21 | 0 | -36 | 13 | 3 |
| 31 Mar 21 | 0 | -41 | 16 | 4 |
| 31 Dec 20 | 0 | -22 | 13 | 3 |
| 30 Sep 20 | 0 | -21 | 12 | 3 |
| 30 Jun 20 | 0 | -18 | 12 | 3 |
| 31 Mar 20 | 0 | -10 | 5 | 2 |
| 31 Dec 19 | 0 | -9 | 5 | 2 |
| 30 Sep 19 | 0 | -8 | 4 | 1 |
| 30 Jun 19 | 0 | -6 | 3 | 1 |
| 31 Mar 19 | 1 | -4 | 2 | 1 |
| 31 Dec 18 | 0 | -3 | 2 | 1 |
| 31 Mar 18 | 0 | -1 | 1 | 0 |
Quality Earnings: CRKN is currently unprofitable.
Growing Profit Margin: CRKN is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: CRKN is unprofitable, and losses have increased over the past 5 years at a rate of 18.5% per year.
Accelerating Growth: Unable to compare CRKN's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: CRKN is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (-11.9%).
Return on Equity
High ROE: CRKN has a negative Return on Equity (-619.71%), as it is currently unprofitable.